Annis Gardner Whiting Capital Advisors, LLC Gilead Sciences, Inc. Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $357 Billion
- Q4 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 352 shares of GILD stock, worth $36,636. This represents 0.01% of its overall portfolio holdings.
Number of Shares
352
Previous 136
158.82%
Holding current value
$36,636
Previous $11.4 Million
185.14%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding GILD
# of Institutions
2,072Shares Held
1.02BCall Options Held
9.63MPut Options Held
10.2M-
Black Rock Inc. New York, NY121MShares$12.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.46 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.28 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.03 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $130B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...